Evolving Regulatory Positions and Legacy Data Challenges: A Case Study of Fludioxonil’s Unknown Metabolite Fraction MF2 in European Active Ingredient Renewal. AJEER. 2025;1(1):1-7. doi:10.70844/ajeer.2025.1.7